The evolution of drug-resistant malaria.
暂无分享,去创建一个
[1] A. Djimde,et al. Monitoring and deterring drug-resistant malaria in the era of combination therapy. , 2007, The American journal of tropical medicine and hygiene.
[2] H. Joshi,et al. World Antimalarial Resistance Network (WARN) III: Molecular markers for drug resistant malaria , 2007, Malaria Journal.
[3] S. Meshnick,et al. Pfmdr1 and in vivo resistance to artesunate-mefloquine in falciparum malaria on the Cambodian-Thai border. , 2007, The American journal of tropical medicine and hygiene.
[4] T. Taylor,et al. Return of chloroquine antimalarial efficacy in Malawi. , 2006, The New England journal of medicine.
[5] B. Sharp,et al. Intercontinental Spread of Pyrimethamine-Resistant Malaria , 2004, Science.
[6] J. Kublin,et al. Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. , 2003, The Journal of infectious diseases.
[7] C. Plowe,et al. Origin and dissemination of Plasmodium falciparum drug-resistance mutations in South America. , 2002, The Journal of infectious diseases.
[8] John C. Wootton,et al. Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum , 2002, Nature.
[9] J. Kublin,et al. Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. , 2002, The Journal of infectious diseases.
[10] J. Wootton,et al. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. , 2000, Molecular cell.
[11] O. Doumbo,et al. Rapid selection of Plasmodium falciparum dihydrofolate reductase mutants by pyrimethamine prophylaxis. , 2000, The Journal of infectious diseases.
[12] O. Doumbo,et al. P. falciparum dihydrofolate reductase and dihydropteroate synthase mutations: epidemiology and role in clinical resistance to antifolates. , 1998, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[13] T. Wellems,et al. Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[14] D. Clyde,et al. Resistance of Plasmodium falciparum in Tanganyika to pyrimethamine administered at weekly intervals. , 1957, Transactions of the Royal Society of Tropical Medicine and Hygiene.